View in EDS PDF Full Text

Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy.

Saved in:
Bibliographic Details
Title: Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy.
Authors: Stewart SB; Department of Urology, Mayo Clinic, Rochester, MN, USA., Cheville JC; Department of Pathology, Mayo Clinic, Rochester, MN, USA., Sebo TJ; Department of Pathology, Mayo Clinic, Rochester, MN, USA., Frank I; Department of Urology, Mayo Clinic, Rochester, MN, USA., Boorjian SA; Department of Urology, Mayo Clinic, Rochester, MN, USA., Thompson RH; Department of Urology, Mayo Clinic, Rochester, MN, USA., Gettman MT; Department of Urology, Mayo Clinic, Rochester, MN, USA., Tollefson MK; Department of Urology, Mayo Clinic, Rochester, MN, USA., Umbriet EC; Department of Urology, Mayo Clinic, Rochester, MN, USA., Psutka SP; Department of Urology, Mayo Clinic, Rochester, MN, USA., Bergstralh EJ; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA., Rangel L; Department of Biostatistics, Mayo Clinic, Rochester, MN, USA., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Source: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2014 Dec; Vol. 17 (4), pp. 332-7. Date of Electronic Publication: 2014 Aug 26.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9815755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5608 (Electronic) Linking ISSN: 13657852 NLM ISO Abbreviation: Prostate Cancer Prostatic Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5608
DOI:10.1038/pcan.2014.30